Tradition Wealth Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-152
Closed -$6K 1390
2023
Q2
$6K Hold
152
﹤0.01% 1165
2023
Q1
$9K Hold
152
﹤0.01% 1029
2022
Q4
$11K Hold
152
﹤0.01% 891
2022
Q3
$12K Hold
152
﹤0.01% 889
2022
Q2
$11K Hold
152
﹤0.01% 803
2022
Q1
$13K Hold
152
﹤0.01% 833
2021
Q4
$11K Hold
152
﹤0.01% 899
2021
Q3
$18K Hold
152
﹤0.01% 759
2021
Q2
$34K Buy
+152
New +$29.6K 0.01% 634

Other funds holding NVCR

Tradition Wealth Management's NVCR Position: Q3 2023 in Review

Tradition Wealth Management sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 152 shares — an estimated $6K sold.

Tradition Wealth Management first reported a position in NVCR in Q2 2021 and held it in 9 quarters. The position peaked at $34K in Q2 2021. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.

  • Tradition Wealth Management reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
  • Tradition Wealth Management sold 152 NovoCure shares in Q3 2023, an estimated $6K.
  • Tradition Wealth Management first reported a position in NovoCure in Q2 2021 and held it in 9 quarters.
  • Tradition Wealth Management's NovoCure position peaked at $34K in Q2 2021.
  • 226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.

Based on Tradition Wealth Management's 13F filing for Q3 2023, filed 13 Nov 2023.